The central role of the gut in intensive care

[1]  D. Scherbak,et al.  PROBIOTIC ADMINISTRATION IS ASSOCIATED WITH INCREASED MORTALITY IN ICU PATIENTS WITH CENTRAL VENOUS CATHETERS , 2022, Chest.

[2]  G. Pesole,et al.  Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  F. McCullough,et al.  The safety and efficacy of probiotic supplementation for critically ill adult patients: a systematic review and meta-analysis , 2022, Nutrition reviews.

[4]  Longhui Li,et al.  The Significance of NLRP Inflammasome in Neuropsychiatric Disorders , 2022, Brain sciences.

[5]  A. Moschetta,et al.  Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code” , 2022, Nutrients.

[6]  J. Chen,et al.  Probiotic Supplementation Prevents the Development of Ventilator-Associated Pneumonia for Mechanically Ventilated ICU Patients: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials , 2022, Frontiers in Nutrition.

[7]  Z. Deng,et al.  Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial , 2022, Frontiers in Cellular and Infection Microbiology.

[8]  A. C. Manetti,et al.  Traumatic Brain Injury and Gut Brain Axis: The Disruption of an Alliance. , 2022, Reviews on recent clinical trials.

[9]  Chih-Cheng Lai,et al.  Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials , 2022, Expert review of anti-infective therapy.

[10]  F. Centrone,et al.  COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles , 2022, Infectious disease reports.

[11]  Chunbo Chen,et al.  Sepsis-Induced Gut Dysbiosis Mediates the Susceptibility to Sepsis-Associated Encephalopathy in Mice , 2022, mSystems.

[12]  V. Giridharan,et al.  A crosstalk between gut and brain in sepsis-induced cognitive decline , 2022, Journal of neuroinflammation.

[13]  T. Szakmany,et al.  Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials , 2022, Nutrients.

[14]  M. Del Fabbro,et al.  Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the Literature , 2022, International journal of molecular sciences.

[15]  C. Tong,et al.  The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut , 2022, Critical Care.

[16]  J. Wortman,et al.  SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. , 2022, The New England journal of medicine.

[17]  J. Timsit,et al.  The role of the microbiota in the management of intensive care patients , 2022, Annals of Intensive Care.

[18]  S. Choi,et al.  Role of Probiotics in the Management of COVID-19: A Computational Perspective , 2022, Nutrients.

[19]  F. Duška,et al.  Multi-donor Fecal Microbial Transplantation for Critically Ill Patients: Rationale and Standard Operating Procedure , 2021, Future Pharmacology.

[20]  Myung-Gyu Kim,et al.  Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect , 2021, Kidney research and clinical practice.

[21]  Juliana Gondim de Albuquerque,et al.  Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19? , 2021, Nutrition research reviews.

[22]  A. Chorti,et al.  A FOUR PROBIOTIC PREPARATION FOR VENTILATOR-ASSOCIATED PNEUMONIA IN MULTI-TRAUMA PATIENTS: RESULTS OF A RANDOMIZED CLINICAL TRIAL. , 2021, International journal of antimicrobial agents.

[23]  Paul W. Dul,et al.  Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial. , 2021, JAMA.

[24]  Ryan M. Thomas,et al.  Bacteria and Sepsis: Microbiome to the Rescue? , 2021, Journal of clinical medicine.

[25]  S. Halvorsen,et al.  Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial , 2021, EBioMedicine.

[26]  Qifang Zhang,et al.  Activation of NLRP3 Inflammasome and Onset of Alzheimer’s Disease , 2021, Frontiers in Immunology.

[27]  M. Connelly,et al.  Circulating trimethylamine‐N‐oxide is associated with all‐cause mortality in subjects with nonalcoholic fatty liver disease , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[28]  Mahavir Singh,et al.  Rebuilding Microbiome for Mitigating Traumatic Brain Injury: Importance of Restructuring the Gut-Microbiome-Brain Axis , 2021, Molecular Neurobiology.

[29]  Xiaochuan Sun,et al.  Fecal Microbiota Transplantation Is a Promising Method to Restore Gut Microbiota Dysbiosis and Relieve Neurological Deficits after Traumatic Brain Injury , 2021, Oxidative medicine and cellular longevity.

[30]  OUP accepted manuscript , 2021, Journal of Antimicrobial Chemotherapy.

[31]  F. Ronchi,et al.  The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology , 2020, Frontiers in Immunology.

[32]  J. P. de Rivero Vaccari,et al.  Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets , 2020, Journal of neuroinflammation.

[33]  J. Pu,et al.  NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin , 2020, Neuroscience.

[34]  Jennifer R. Defazio,et al.  The use of fecal microbiota transplant in sepsis. , 2020, Translational research : the journal of laboratory and clinical medicine.

[35]  Annika Lundqvist,et al.  The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study. , 2020, Cell metabolism.

[36]  W. Jia,et al.  Age-related compositional changes and correlations of gut microbiome, serum metabolome, and immune factor in rats , 2020, GeroScience.

[37]  B. Shakhsheer,et al.  Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity , 2020, Nature Communications.

[38]  Huiping Xu,et al.  Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  Y. Liu,et al.  High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients , 2019, BMC Nephrology.

[40]  Kok Jf,et al.  Ribaxamase, an orally administered β-lactamase, protects the gut microbiome in patients treated with ceftriaxone , 2020 .

[41]  R. Amathieu,et al.  Management of liver failure in General Intensive Care Unit. , 2020, Anaesthesia, critical care & pain medicine.

[42]  P. Anderson,et al.  The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition , 2019, Nutrients.

[43]  N. Shime,et al.  Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome , 2019, Respiratory Research.

[44]  Miriam H. Huntley,et al.  Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant. , 2019, The New England journal of medicine.

[45]  R. Bataller,et al.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease , 2019, Nature.

[46]  A. Gasbarrini,et al.  Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition , 2019, Nutrients.

[47]  Ruifu Yang,et al.  Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae. , 2019, Cell metabolism.

[48]  W. Ling,et al.  Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease. , 2019, Molecular nutrition & food research.

[49]  C. Mackay,et al.  Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic‐ and GPR109a‐mediated mechanisms , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  M. Derrien,et al.  The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response , 2019, Scientific Reports.

[51]  C. Coopersmith,et al.  The microbiome and nutrition in critical illness , 2019, Current opinion in critical care.

[52]  F. Ding,et al.  Serum indoxyl sulfate is associated with mortality in hospital-acquired acute kidney injury: a prospective cohort study , 2019, BMC Nephrology.

[53]  A. Parian,et al.  Fecal Microbiota Transplantation for the Critically Ill Patient , 2018, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[54]  C. Pichard,et al.  ESPEN guideline on clinical nutrition in the intensive care unit. , 2019, Clinical nutrition.

[55]  E. Kuijper,et al.  Clinical Application and Potential of Fecal Microbiota Transplantation. , 2019, Annual review of medicine.

[56]  P. Stenvinkel,et al.  Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study , 2019, Probiotics and Antimicrobial Proteins.

[57]  C. B. de La Serre,et al.  Microbiota modulation by eating patterns and diet composition: impact on food intake. , 2018, American journal of physiology. Regulatory, integrative and comparative physiology.

[58]  M. Hattori,et al.  Gut microbiota-derived D-serine protects against acute kidney injury. , 2018, JCI insight.

[59]  A. Gasbarrini,et al.  Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions , 2018, Alimentary pharmacology & therapeutics.

[60]  T. Spector,et al.  Role of the gut microbiota in nutrition and health , 2018, British Medical Journal.

[61]  F. Hugenholtz,et al.  The emerging role of the microbiota in the ICU , 2018, Critical Care.

[62]  D. Jain,et al.  Translocation of a gut pathobiont drives autoimmunity in mice and humans , 2018, Science.

[63]  N. Ampel.  Blunting the Effects of Antibiotics on the Intestinal Microbiome , 2018 .

[64]  D. Raoult,et al.  Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  J. Kaczmarek,et al.  Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota. , 2017, The American journal of clinical nutrition.

[66]  Huiping Xu,et al.  Fecal Microbiota Transplant Decreases Mortality in Patients With Refractory Severe and Severe Complicated Clostridium difficile Infection Not Eligible for Colectomy: 2017 Fellows-in-Training Award (Colon Category): 100 , 2017 .

[67]  Robert D. Stedtfeld,et al.  Modulatory Influence of Segmented Filamentous Bacteria on Transcriptomic Response of Gnotobiotic Mice Exposed to TCDD , 2017, Front. Microbiol..

[68]  G. Cresci,et al.  Prophylactic tributyrin treatment mitigates chronic‐binge ethanol‐induced intestinal barrier and liver injury , 2017, Journal of gastroenterology and hepatology.

[69]  I. Komuro,et al.  Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure , 2017, Korean circulation journal.

[70]  J. de Gunzburg,et al.  Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis , 2017, Antimicrobial Agents and Chemotherapy.

[71]  N. Bhala,et al.  Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection , 2017, Alimentary pharmacology & therapeutics.

[72]  M. Bertrand,et al.  RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis. , 2017, Journal of hepatology.

[73]  H. Tilg,et al.  Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease , 2017, Gut.

[74]  A. El-Osta,et al.  High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.

[75]  R. Kelishadi,et al.  Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents , 2017, Journal of pediatric gastroenterology and nutrition.

[76]  H. Tilg,et al.  European consensus conference on faecal microbiota transplantation in clinical practice , 2017, Gut.

[77]  Huiping Xu,et al.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach , 2016, Gut microbes.

[78]  M. Fischbach,et al.  Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. , 2016, Cell host & microbe.

[79]  P. Popovich,et al.  Gut dysbiosis impairs recovery after spinal cord injury , 2016, The Journal of experimental medicine.

[80]  T. van der Poll,et al.  Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study , 2016, Intensive Care Medicine.

[81]  Dongfeng Chen,et al.  Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis , 2016, Critical Care.

[82]  S. Tzipori,et al.  Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection. , 2016, Anaerobe.

[83]  Rob Knight,et al.  Extreme Dysbiosis of the Microbiome in Critical Illness , 2016, mSphere.

[84]  A. Waisman,et al.  Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction , 2016, Journal of the American Heart Association.

[85]  P. Wischmeyer,et al.  Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis , 2016, Critical Care.

[86]  A. Levin,et al.  Neonatal gut microbiota associates with childhood multi–sensitized atopy and T–cell differentiation , 2016, Nature Medicine.

[87]  S. Roos,et al.  Lactobacillus reuteri increases mucus thickness and ameliorates dextran sulphate sodium‐induced colitis in mice , 2016, Acta physiologica.

[88]  R. Knight,et al.  Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness , 2016, Current opinion in critical care.

[89]  A. Xu,et al.  Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice , 2016, Circulation.

[90]  Jennifer R. Defazio,et al.  The Shift of an Intestinal “Microbiome” to a “Pathobiome” Governs the Course and Outcome of Sepsis Following Surgical Injury , 2016, Shock.

[91]  A. Day,et al.  Enteral versus parenteral nutrition in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials , 2016, Critical Care.

[92]  O. Mathieu,et al.  Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  R. Aquilani,et al.  Pathogenic Gut Flora in Patients With Chronic Heart Failure. , 2016, JACC. Heart failure.

[94]  P. Stenvinkel,et al.  Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease , 2016, PloS one.

[95]  Hong-wei Zhang,et al.  Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults , 2016, Scientific Reports.

[96]  R. Milo,et al.  Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.

[97]  B. Shenderov,et al.  Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota , 2016, Microbial ecology in health and disease.

[98]  S. Hazen,et al.  Choline Diet and Its Gut Microbe–Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload–Induced Heart Failure , 2016, Circulation. Heart failure.

[99]  M. Wong,et al.  Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition , 2015, Molecular Psychiatry.

[100]  R. Dickson.  The microbiome and critical illness. , 2016, The Lancet. Respiratory medicine.

[101]  L. Eckmann,et al.  Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury. , 2015, Alcoholism, clinical and experimental research.

[102]  T. van der Poll,et al.  The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia , 2015, Gut.

[103]  Xinying Wang,et al.  Partial Enteral Nutrition Preserves Elements of Gut Barrier Function, Including Innate Immunity, Intestinal Alkaline Phosphatase (IAP) Level, and Intestinal Microbiota in Mice , 2015, Nutrients.

[104]  H. Sokol,et al.  Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease , 2015, Gut.

[105]  Rustem F. Ismagilov,et al.  Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis , 2015, Cell.

[106]  M. Silver,et al.  Impact of the Dash Diet on Endothelial Function, Exercise Capacity, and Quality of Life in Patients with Heart Failure , 2015, Proceedings.

[107]  Jun Gu,et al.  Klotho Protects Against Indoxyl Sulphate-Induced Myocardial Hypertrophy. , 2015, Journal of the American Society of Nephrology : JASN.

[108]  Seppo Salminen,et al.  A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial , 2015, Pediatric Research.

[109]  E. Mesquita,et al.  Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial. , 2015, International journal of cardiology.

[110]  Omry Koren,et al.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome , 2015, Nature.

[111]  S. Hazen,et al.  The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. , 2015, Annual review of medicine.

[112]  Vinícius Andrade-Oliveira,et al.  Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. , 2015, Journal of the American Society of Nephrology : JASN.

[113]  Young Don Kim,et al.  Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study , 2014, European journal of gastroenterology & hepatology.

[114]  K. Nelson,et al.  Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. , 2015, Gastroenterology.

[115]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[116]  Therapeutic Modulation and Reestablishment of the Intestinal Microbiota With Fecal Microbiota Transplantation Resolves Sepsis and Diarrhea in a Patient , 2014, The American Journal of Gastroenterology.

[117]  B. Shakhsheer,et al.  Membership and Behavior of Ultra-Low-Diversity Pathogen Communities Present in the Gut of Humans during Prolonged Critical Illness , 2014, mBio.

[118]  S. Anker,et al.  Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. , 2014, Journal of the American College of Cardiology.

[119]  H. Rabb,et al.  Intestinal Microbiota-Kidney Cross Talk in Acute Kidney Injury and Chronic Kidney Disease , 2014, Nephron Clinical Practice.

[120]  J. Chastre,et al.  Antibiotic stewardship in the intensive care unit , 2014, Critical Care.

[121]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[122]  W. D. de Vos,et al.  The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.

[123]  G. Gloor,et al.  Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat , 2014, Circulation. Heart failure.

[124]  G. Andersen,et al.  Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD , 2014, American Journal of Nephrology.

[125]  T. Junt,et al.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis , 2014, Nature Medicine.

[126]  C. Buffie,et al.  Microbiota-mediated colonization resistance against intestinal pathogens , 2013, Nature Reviews Immunology.

[127]  S. Zeisel,et al.  Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[128]  P. Wischmeyer,et al.  Probiotic Administration Reduces Mortality and Improves Intestinal Epithelial Homeostasis in Experimental Sepsis , 2013, Anesthesiology.

[129]  G. Xie,et al.  Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. , 2013, Journal of proteome research.

[130]  J. Gordon,et al.  Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.

[131]  Rob Knight,et al.  Defining the human microbiome. , 2012, Nutrition reviews.

[132]  K. Brown,et al.  Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease , 2012, Nutrients.

[133]  J. Kabeerdoss,et al.  Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers , 2011, Nutrition journal.

[134]  F. Bushman,et al.  Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.

[135]  M. Kollef,et al.  Antibiotic stewardship in the intensive care unit. , 2011, Seminars in respiratory and critical care medicine.

[136]  M. Hayakawa,et al.  Dramatic Changes of the Gut Flora Immediately After Severe and Sudden Insults , 2011, Digestive Diseases and Sciences.

[137]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[138]  A. Fodor,et al.  Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. , 2011, Gastroenterology.

[139]  J. Tieppo,et al.  Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. , 2011, Arquivos de gastroenterologia.

[140]  Z. Tonar,et al.  Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. , 2010, Journal of atherosclerosis and thrombosis.

[141]  A. Wolk,et al.  Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. , 2009, The American journal of cardiology.

[142]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[143]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[144]  I. Baguley,et al.  Dysautonomia after Severe Traumatic Brain Injury: Evidence of Persisting Overresponsiveness to Afferent Stimuli , 2009, American journal of physical medicine & rehabilitation.

[145]  Naomi Jones,et al.  The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study , 2009, Intensive Care Medicine.

[146]  A. Wolk,et al.  Consistency with the DASH diet and incidence of heart failure. , 2009, Archives of internal medicine.

[147]  B. Roth,et al.  The expanded biology of serotonin. , 2009, Annual review of medicine.

[148]  K. Zimmermann,et al.  Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans , 2009, Mucosal Immunology.

[149]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[150]  K. Fellermann,et al.  Probiotic lactobacilli and VSL#3 induce enterocyte β‐defensin 2 , 2008, Clinical and experimental immunology.

[151]  E. Benarroch,et al.  Enteric nervous system , 2007, Neurology.

[152]  P. Poole‐Wilson,et al.  Altered intestinal function in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.

[153]  C. Coopersmith,et al.  INTESTINAL CROSSTALK: A NEW PARADIGM FOR UNDERSTANDING THE GUT AS THE "MOTOR" OF CRITICAL ILLNESS , 2007, Shock.

[154]  T. Fiore,et al.  Jaundice in critical illness: promoting factors of a concealed reality , 2006, Intensive Care Medicine.

[155]  Y. Chida,et al.  Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice , 2004, The Journal of physiology.

[156]  Ji-Xin Shi,et al.  Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction. , 2004, World journal of gastroenterology.

[157]  Jeffrey B. Cheng,et al.  Molecular Genetics of 3β-Hydroxy-Δ5-C27-Steroid Oxidoreductase Deficiency in 16 Patients with Loss of Bile Acid Synthesis and Liver Disease , 2003 .

[158]  D. Sachar,et al.  Pulmonary Manifestations of Inflammatory Bowel Disease , 2003, Inflammatory bowel diseases.

[159]  P. Koski,et al.  Enzymic degradation of a beta-lactam antibiotic, ampicillin, in the gut: a novel treatment modality. , 2003, The Journal of antimicrobial chemotherapy.

[160]  Jeffrey B. Cheng,et al.  Molecular genetics of 3beta-hydroxy-Delta5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. , 2003, The Journal of clinical endocrinology and metabolism.

[161]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[162]  S. Atiş,et al.  Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome , 2001, American Journal of Gastroenterology.

[163]  D. Cockcroft,et al.  Constrictive bronchiolitis and ulcerative colitis. , 1999, Canadian respiratory journal.

[164]  A. Wells,et al.  Bronchiectasis following colectomy for Crohn’s disease , 1998, Thorax.

[165]  D. Russell,et al.  Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. , 1996, The Journal of biological chemistry.

[166]  D. Jenden,et al.  Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.

[167]  D. Jenden,et al.  Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. , 1993, Clinical nutrition.

[168]  R. H. Earle,et al.  Unexplained bronchopulmonary disease with inflammatory bowel disease. , 1976, Archives of internal medicine.

[169]  G. Bertaccini.  Tissue 5‐hydroxytryptamine and urinary 5‐hydroxyindoleacetic acid after partial or total removal of the gastro‐intestinal tract in the rat , 1960, The Journal of physiology.

[170]  V. Erspamer,et al.  Observations on the Release and Turnover Rate of 5‐Hydroxytryptamine in the Gastrointestinal Tract , 1959, The Journal of pharmacy and pharmacology.

[171]  A. J. Wood,et al.  Action of Enterobacteriaceae on Choline and Related Compounds , 1947 .